Skip to content

Individual Dietary Counseling Based on Taste-tests in Patients With Hematological Cancer in Cytostatic Therapy

Individuel diætvejledning på Baggrund af Smagstest Hos Patienter Med hæmatologisk Cancer i Cytostatisk Behandling

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05364359
Acronym
HCP
Enrollment
40
Registered
2022-05-06
Start date
2022-03-28
Completion date
2022-08-15
Last updated
2022-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological Malignancy

Keywords

cancer, hematological, malignancy

Brief summary

The purpose of the study is to investigate whether a simple taste-test will increase the intake of energy as part of the individual dietary counseling.

Detailed description

The investigators will investigate the tastes (umami, bitter, salty, sweet and sour) that the patients prefers in order to increase the energy intake and reduce the risk of weight loss and loss of fat-free mass for patients with hematological cancer. The study will be conducted as a single blinded randomized controlled trial. 40 patients will be recruited, and will be divided into two groups; the intervention group and the control group. The patients will not know which group they belong to.

Interventions

DIETARY_SUPPLEMENTTaste-test

Patients will receive a dietary counseling based on a simple taste-test

OTHERStandard care

Patients will receive a dietary counseling based on a standard dietary counseling for the patient group

Sponsors

Zealand University Hospital
CollaboratorOTHER
University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* 18 years or older * Able to understand the Participant Information paper * Diagnosed with hematological cancer * Must be undergoing chemotherapy (at least one treatment during the study) * Outpatient * Be able to take pictures of meals (and send to the sub-investigators) * Be able to speak and read the danish language

Exclusion criteria

* Pacemaker

Design outcomes

Primary

MeasureTime frameDescription
Consumption of energy as a percentage of estimated need6 weeksdifference - before and after intervention

Secondary

MeasureTime frameDescription
Satisfaction (measured with EROTC QLQ-C30 version 3.0)6 weeksdifference - before and after intervention. Higher scores means worse outcome. Lower scores means better outcomes.
Hand-grip-strength (measured with a dynamometer)6 weeksdifference - before and after intervention
Fat-free-mass and fat-mass in percent (bioimpedance measurement)6 weeksdifference - before and after intervention
Protein intake6 weeksdifference - before and after intervention
Burning/pain in the mouth (measured on a scale)6 weeksdifference - before and after intervention measured with Likert scale (1 to 5). Higher scores means a worse outcome. Lower scores means better outcomes.
Body weight6 weeksdifference - before and after intervention

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026